Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure

1995323 citationsJournal Articlegreen Open Access

Authors

N.A.T. Hamdy · University of Sheffield

J. A. Kanis · University of Sheffield

M.N.C. Benéton · University of Sheffield

C. B. Brown · Northern General Hospital

J.R. Juttmann · Elisabeth-TweeSteden Ziekenhuis

J. G. M. Jordans · Medisch Spectrum Twente

S. Josse ·

Abstract

Early administration of alfacalcidol can safely and beneficially alter the natural course of renal bone disease in patients with mild to moderate renal failure.

Topics & Keywords

Parathyroid Disorders and Treatments Bone health and osteoporosis research Pharmacological Effects and Toxicity Studies

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: BMJ

Volume 310, Issue 6976, pp. 358-363

DOI: 10.1136/bmj.310.6976.358

Field-Weighted Citation Impact: 7.12